HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.

Abstract
We have recently shown that direct injection of DNA can be an effective vaccine strategy eliciting both humoral and cell-mediated immune responses. Vectors were designed specifically for vaccination by direct DNA injection and refined to improve plasmid production in Escherichia coli. The vectors consist of a pUC-19 backbone with the cytomegalovirus (CMV) IE1 enhancer, promoter, and intron A transcription regulatory elements and the BGH polyadenylation sequences driving the expression of the reporter gene CAT or influenza A nucleoprotein (NP) or hemagglutinin (HA). The respective vectors expressed high levels of chloramphenicol acetyltransferase (CAT) and NP in tissue culture, and yielded 14-15 mg of purified plasmid per liter of Escherichia coli culture. Immunization of mice with the NP and HA expression vectors resulted in protection from subsequent lethal challenges of influenza using either heterologous or homologous strains, respectively.
AuthorsD L Montgomery, J W Shiver, K R Leander, H C Perry, A Friedman, D Martinez, J B Ulmer, J J Donnelly, M A Liu
JournalDNA and cell biology (DNA Cell Biol) Vol. 12 Issue 9 Pg. 777-83 (Nov 1993) ISSN: 1044-5498 [Print] United States
PMID8216848 (Publication Type: Journal Article)
Chemical References
  • Hemagglutinins, Viral
  • Influenza Vaccines
  • Nucleocapsid Proteins
  • Nucleoproteins
  • Vaccines, Synthetic
  • Viral Core Proteins
  • Viral Structural Proteins
Topics
  • Animals
  • Female
  • Gene Expression
  • Genes, Viral
  • Genetic Vectors
  • Hemagglutinins, Viral (genetics, immunology)
  • Influenza A virus (immunology)
  • Influenza Vaccines (genetics)
  • Mice
  • Mice, Inbred BALB C
  • Nucleocapsid Proteins
  • Nucleoproteins
  • Orthomyxoviridae Infections (prevention & control)
  • Promoter Regions, Genetic
  • Transfection
  • Vaccines, Synthetic (administration & dosage, immunology)
  • Viral Core Proteins (genetics, immunology)
  • Viral Structural Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: